Instrument for Glaucoma Early Detection and Monitoring

NCT00578110 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2010-04-02

No results posted yet for this study

Summary

To introduce a rapid and objective electrophysiological technique that can assess visual function in the magnocellular pathway, which is thought to be affected in early-stage glaucoma.

Conditions

Interventions

DEVICE

Glaucoma Diagnosis, Name: Neucodia

Sensitivity and Specificity

Sponsors & Collaborators

  • Yale University

    collaborator OTHER
  • University of Alabama at Birmingham

    collaborator OTHER
  • University of Tennessee

    collaborator OTHER
  • Synabridge Corporation

    lead INDUSTRY

Principal Investigators

  • George Hu, Ph.D. · Synabridge Corp.

  • James Tsai, M.D. · Yale University

  • Max Forbes, M.D. · Columbia University

  • Vivienne Greenstein, Ph.D. · Columbia University

  • Eugenue Hartmann, Ph.D. · University of Alabama at Birmingham

  • Peter Netland, M.D. Ph.D. · University of Tennessee

  • Leo Pau Semes, O.D. · University of Alabama at Birmingham

  • Vance M Zemon, Ph.D. · Yeshiva University

  • Sarwat Salim, MD · University of Tennessee

  • Mark Swanson, OD · University of Alabama at Birmingham

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00578110 on ClinicalTrials.gov